VANCOUVER, BRITISH COLUMBIA, June 16, 2021- Pascal Biosciences Inc. (“Pascal”) (TSXV:PAS) (OTC:PSCBF) (FSE: 6PB), announced today the appointment of Hardy Forzley as Chief Financial Officer. Mr. Forzley has used his professional expertise as a Certified Public Accountant with some 30 years…

VANCOUVER, BRITISH COLUMBIA, June 8, 2021- Pascal Biosciences Inc. (“Pascal” or the “Company”) (TSXV:PAS) (OTC:PSCBF), has been awarded a grant of US$343,750 from the National Cancer Institute of the US National Institutes of Health (NIH).  This two-year award will fund…

VANCOUVER, BRITISH COLUMBIA, June 2, 2021- Pascal Biosciences Inc. (“Pascal” or the “Company”) (TSXV:PAS) (OTC:PSCBF, previously BIMUF), has today received a new Over The Counter (OTC) trading symbol following acceptance of Form 211 by the US Financial Industry Regulatory Authority…